Compare EHTH & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EHTH | SERA |
|---|---|---|
| Founded | 1997 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Precision Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.0M | 107.3M |
| IPO Year | 2006 | 2021 |
| Metric | EHTH | SERA |
|---|---|---|
| Price | $1.65 | $2.09 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $5.33 | N/A |
| AVG Volume (30 Days) | ★ 989.1K | 23.8K |
| Earning Date | 05-22-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 71.43 | 14.66 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $251,395,000.00 | $77,000.00 |
| Revenue This Year | $0.30 | $25.84 |
| Revenue Next Year | $6.14 | $715.79 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 45.86 | N/A |
| 52 Week Low | $1.20 | $1.37 |
| 52 Week High | $8.55 | $4.35 |
| Indicator | EHTH | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 38.49 | 27.66 |
| Support Level | N/A | $1.37 |
| Resistance Level | $1.93 | $3.45 |
| Average True Range (ATR) | 0.19 | 0.21 |
| MACD | 0.06 | -0.02 |
| Stochastic Oscillator | 59.74 | 16.03 |
eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is from the United States. It also has a presence in China.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.